Deutetrabenazine

Introduction: What is Deutetrabenazine?

Deutetrabenazine is a prescription medication primarily used to treat movement disorders. It is particularly effective for conditions characterized by involuntary movements, such as chorea associated with Huntington's disease. Deutetrabenazine is a deuterated derivative of tetrabenazine, designed to provide similar therapeutic benefits with longer duration of action and potentially improved tolerability due to its slower metabolism.

Uses of Deutetrabenazine

Deutetrabenazine is approved for the treatment of:

• Chorea associated with Huntington's disease: This condition involves involuntary, erratic movements that can significantly impact daily life.
• Tardive dyskinesia: A movement disorder resulting from long-term use of antipsychotic medications, characterized by repetitive, involuntary movements.
• Other movement disorders: While primarily indicated for the above conditions, it may also be used off-label for other movement-related issues as determined by a healthcare provider.

How It Works

Deutetrabenazine works by inhibiting the vesicular monoamine transporter 2 (VMAT2), a protein responsible for transporting neurotransmitters like dopamine into vesicles in nerve cells. By blocking VMAT2, deutetrabenazine reduces the amount of dopamine available for release into the synaptic cleft, thereby decreasing the excessive movements seen in these neurological conditions. In simpler terms, it helps to calm down the overactive signals in the brain that lead to involuntary movements.

Dosage and Administration

The standard dosage of deutetrabenazine varies based on the condition being treated and individual patient factors.

• Adults: The typical starting dose is 6 mg per day, which may be increased gradually based on response and tolerability. The maximum recommended dose is 48 mg per day, divided into multiple doses.
• Pediatric Use: Safety and efficacy in children have not been established, so it is generally not recommended for pediatric patients.

Deutetrabenazine is administered orally in the form of tablets, which should be taken with food to enhance absorption. It is important to follow the prescribing physician's instructions regarding dosage adjustments and frequency.

Side Effects of Deutetrabenazine

Common side effects may include:

• Drowsiness
• Fatigue
• Nausea
• Diarrhea
• Insomnia

Serious side effects can include:

• Depression or worsening of mood
• Suicidal thoughts or behaviors
• Extrapyramidal symptoms (such as parkinsonism, akathisia, or dystonia)
• Severe allergic reactions

Patients should report any unusual or severe side effects to their healthcare provider immediately.

Drug Interactions

Deutetrabenazine can interact with several medications, which may increase the risk of side effects or reduce its effectiveness. Major drug interactions include:

• Monoamine oxidase inhibitors (MAOIs): Concurrent use can lead to severe side effects.
• Antidepressants: Antidepressants (especially SSRIs and SNRIs) can increase deutetrabenazine plasma levels and the risk of sedation or QT prolongation, rather than serotonin syndrome.
• Other medications affecting dopamine levels: Caution is advised when used with other drugs that influence dopamine, as this can exacerbate side effects.

Always inform your healthcare provider about all medications, supplements, and herbal products you are taking.

Benefits of Deutetrabenazine

The clinical advantages of using deutetrabenazine include:

• Targeted action: Specifically designed to address movement disorders, providing relief from involuntary movements.
• Improved tolerability: Some patients may experience fewer side effects compared to traditional treatments like tetrabenazine.
• Convenient dosing: Available in tablet form, making it easy to incorporate into daily routines.

Contraindications of Deutetrabenazine

Deutetrabenazine should be avoided in certain populations, including:

• Pregnant or breastfeeding women: The effects on fetal development and nursing infants are not well studied.
• Patients with liver disease: Liver impairment can affect the metabolism of the drug, increasing the risk of side effects.
• Patients with untreated or inadequately treated depression, or those who are actively suicidal.

Precautions and Warnings

Before starting treatment with deutetrabenazine, patients should undergo a thorough evaluation, including:

• Mental health assessment: To identify any history of depression or suicidal ideation.
• Liver function tests: To ensure the liver can adequately process the medication.
• QT Prolongation: Caution in patients with congenital long QT syndrome or those taking QT-prolonging drugs.
• Neuroleptic Malignant Syndrome: Rare cases have been reported with VMAT2 inhibitors.

Patients should be monitored closely for any changes in mood or behavior during treatment.

Frequently Asked Questions (FAQs)

• What is deutetrabenazine used for? Deutetrabenazine is used to treat chorea associated with Huntington's disease and tardive dyskinesia.
• How does deutetrabenazine work? It works by inhibiting the VMAT2 protein, reducing dopamine release and helping to control involuntary movements.
• What are the common side effects? Common side effects include drowsiness, fatigue, nausea, and diarrhea. Other possible effects include restlessness or anxiety, particularly during dose titration.
• Can I take deutetrabenazine with other medications? Always inform your doctor about all medications, especially CYP2D6 inhibitors, antipsychotics, antidepressants, or QT-prolonging agents, as these may interact.
• Is deutetrabenazine safe during pregnancy? It is not recommended for use during pregnancy due to potential risks to the fetus.
• How should I take deutetrabenazine? It should be taken orally with food, following your doctor's prescribed dosage.
• What should I do if I miss a dose? Take the missed dose as soon as you remember, but skip it if it's almost time for your next dose. Do not double up.
• Can children take deutetrabenazine? Its safety and efficacy in children have not been established, so it is generally not recommended.
• What should I do if I experience severe side effects? Contact your healthcare provider immediately if you experience severe side effects or mood changes.
• How long does it take for deutetrabenazine to work? Patients may start to notice improvements in symptoms within a few weeks, but it can vary by individual.

Brand Names

Deutetrabenazine is marketed under the brand name Austedo.

Conclusion

Deutetrabenazine is a valuable treatment for chorea associated with Huntington?s disease and tardive dyskinesia in adults. Its selective VMAT2 inhibition helps reduce involuntary movements with potentially fewer side effects than older agents. Because it can affect mood and interact with other medications, ongoing medical supervision and monitoring are essential for safe use.